Feverish Quest for Ebola Immunotherapy: Straight or Cocktail?

Trends in Microbiology

Volumn 24, Issue 9, 2016, Pages 684-686

  Saphire, Erica Ollmann ^a   Aman, M Javad ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Integrated BioTherapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN; ZMAPP; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; COMBINATION DRUG THERAPY; DRUG EFFICACY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HUMAN; IMMUNOTHERAPY; MONOTHERAPY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS ENTRY; VIRUS NEUTRALIZATION; ANIMAL; IMMUNOLOGY; MOUSE; PROCEDURES; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; EBOLAVIRUS; EPITOPES; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOTHERAPY; MICE; VIRAL ENVELOPE PROTEINS;

EID: 84990855039     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2016.05.008     Document Type: Note

References (12)

1. 1 Aman, M.J., Chasing ebola through the endosomal labyrinth. mBio, 7, 2016, e00346-16.
2. 2 Lee, J.E., et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454 (2008), 177–182.
3. 3 Wong, G., et al. Post-exposure therapy of filovirus infections. Trends Microbiol. 22 (2014), 456–463.
4. 4 Murin, C.D., et al. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 17182–17187.
5. 5 Furuyama, W., et al. Discovery of an antibody for pan-ebolavirus therapy. Sci. Rep., 6, 2016, 20514.
6. 6 Flyak, A.I., et al. Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection. Cell 164 (2016), 392–405.
7. 7 Bornholdt, Z.A., et al. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science 351 (2016), 1078–1083.
8. 8 Keck, Z.Y., et al. Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein. J. Virol. 90 (2015), 279–291.
9. 9 Corti, D., et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science 351 (2016), 1339–1342.
10. 10 Misasi, J., et al. Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science 351 (2016), 1343–1346.
11. 11 Holtsberg, F.W., et al. Pan-ebolavirus and pan-filovirus mouse monoclonal antibodies: protection against ebola and sudan viruses. J. Virol. 90 (2015), 266–278.
12. 12 Howell, K.A., et al. Antibody treatment of ebola and sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site. Cell Rep. 15 (2016), 1514–1526.